{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:01:34Z","timestamp":1792699294887,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fitoterapia"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.fitote.2025.106990","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:28:11Z","timestamp":1763346491000},"page":"106990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Dual inhibition of angiogenesis by Peucedanum praeruptorum Dunn root extract in endothelial and gefitinib-resistant lung cancer cells"],"prefix":"10.1016","volume":"188","author":[{"given":"Hyun-Ji","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Hyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.fitote.2025.106990_bb0005","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s13402-021-00602-3","article-title":"Angiogenesis as a hallmark of solid tumors - clinical perspectives","volume":"44","author":"Majidpoor","year":"2021","journal-title":"Cell. Oncol. (Dordr)"},{"issue":"1","key":"10.1016\/j.fitote.2025.106990_bb0010","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.fitote.2025.106990_bb0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13046-020-01709-5","article-title":"The role of microenvironment in tumor angiogenesis","volume":"39","author":"Jiang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"14","key":"10.1016\/j.fitote.2025.106990_bb0020","doi-asserted-by":"crossref","first-page":"1200941","DOI":"10.3389\/fimmu.2023.1200941","article-title":"Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy","author":"Shafqat","year":"2023","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.fitote.2025.106990_bb0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fcell.2020.00584","article-title":"Resistance to anti-angiogenic therapies: a mechanism depending on the time of exposure to the drugs","author":"Montemagno","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.fitote.2025.106990_bb0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12943-018-0777-1","article-title":"Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer","volume":"17","author":"Wu","year":"2018","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.fitote.2025.106990_bb0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.21037\/tlcr.2018.05.14","article-title":"Lung cancer in never smokers-the east Asian experience","volume":"7","author":"Zhou","year":"2018","journal-title":"Transl. Lung Cancer Res."},{"issue":"7","key":"10.1016\/j.fitote.2025.106990_bb0040","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jjco\/hyad052","article-title":"Current treatment strategies for EGFR-mutated non-small cell lung cancer: from first line to beyond osimertinib resistance","volume":"53","author":"Araki","year":"2023","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.fitote.2025.106990_bb0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3892\/ijo.2021.5270","article-title":"Mechanisms and management of 3rd generation EGFR TKI resistance in advanced non small cell lung cancer (review)","volume":"59","author":"He","year":"2021","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.fitote.2025.106990_bb0050","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3892\/ol.2021.12932","article-title":"Angiogenic activities are increased via upregulation of HIF-1\u03b1 expression in gefitinib-resistant non-small cell lung carcinoma cells","volume":"22","author":"Cha","year":"2021","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.fitote.2025.106990_bb0055","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jamaoncol.2020.1260","article-title":"Effect of Osimertinib and bevacizumab on progression-free survival for patients with metastatic EGFR-mutant lung cancers: a phase 1\/2 single-group open-label trial","volume":"6","author":"Yu","year":"2020","journal-title":"JAMA Oncol."},{"issue":"15","key":"10.1016\/j.fitote.2025.106990_bb0060","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/1759-7714.14880","article-title":"Osimertinib combined with bevacizumab as the first-line treatment in non-small cell lung cancer patients with brain metastasis harboring epidermal growth factor receptor mutations","volume":"14","author":"Zhang","year":"2023","journal-title":"Thorac Cancer."},{"issue":"15","key":"10.1016\/j.fitote.2025.106990_bb0065","doi-asserted-by":"crossref","first-page":"1352657","DOI":"10.3389\/fphar.2024.1352657","article-title":"The traditional uses, pharmacology, and phytochemistry of Peucedanum praeruptorum Dunn","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.fitote.2025.106990_bb0070","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.3390\/ijms21082919","article-title":"Praeruptorin B mitigates the metastatic ability of human renal carcinoma cells through targeting CTSC and CTSV expression","volume":"21","author":"Lin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.fitote.2025.106990_bb0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/ijms19010010","article-title":"Praeruptorin a inhibits human cervical Cancer cell growth and invasion by suppressing MMP-2 expression and ERK1\/2 signaling","volume":"19","author":"Wu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.fitote.2025.106990_bb0080","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.3390\/molecules27072360","article-title":"The root extract of Peucedanum praeruptorum Dunn exerts anticancer effects in human non-small-cell lung Cancer cells with different EGFR mutation statuses by suppressing MET activity","volume":"27","author":"Park","year":"2022","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.fitote.2025.106990_bb0085","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.3390\/ijms22105181","article-title":"The root extract of Scutellaria baicalensis induces apoptosis in EGFR TKI-resistant human lung Cancer cells by inactivation of STAT3","volume":"22","author":"Park","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.fitote.2025.106990_bb0090","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s12272-025-01545-1","article-title":"Targeting vascular endothelial growth receptor-2 (VEGFR-2): structural biology, functional insights, and therapeutic resistance","volume":"48","author":"Shah","year":"2025","journal-title":"Arch. Pharm. Res."},{"issue":"12","key":"10.1016\/j.fitote.2025.106990_bb0095","first-page":"2092","article-title":"Baseline Ang-2 serum levels as a predictive factor for survival in NSCLC and SCLC","volume":"12","author":"Nikolakopoulou","year":"2022","journal-title":"Life (Basel)."},{"issue":"13","key":"10.1016\/j.fitote.2025.106990_bb0100","doi-asserted-by":"crossref","first-page":"899819","DOI":"10.3389\/fpls.2022.899819","article-title":"Comparative transcriptomics unveil the crucial genes involved in Coumarin biosynthesis in Peucedanum praeruptorum Dunn","author":"Song","year":"2022","journal-title":"Front. Plant Sci."},{"issue":"1","key":"10.1016\/j.fitote.2025.106990_bb0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13045-022-01310-7","article-title":"Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.fitote.2025.106990_bb0110","article-title":"Unveiling novel VEGFR-2 inhibitors: QSAR modeling, molecular docking, MD and MM-GBSA calculations, pharmacokinetics profiling and DFT studies","volume":"28","author":"Abdullahi","year":"2025","journal-title":"Sci. Afr."},{"issue":"8","key":"10.1016\/j.fitote.2025.106990_bb0115","doi-asserted-by":"crossref","first-page":"599281","DOI":"10.3389\/fcell.2020.599281","article-title":"Molecular bases of VEGFR-2-mediated physiological function and pathological role","author":"Wang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.fitote.2025.106990_bb0120","doi-asserted-by":"crossref","first-page":"24460","DOI":"10.1038\/srep24460","article-title":"Discovery of potent VEGFR-2 inhibitors based on furopyrimidine and thienopyrimidne scaffolds as Cancer targeting agents","author":"Aziz","year":"2016","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.fitote.2025.106990_bb0125","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1080\/07391102.2021.1872417","article-title":"Exploration of structural requirements for the inhibition of VEGFR-2 tyrosine kinase: binding site analysis of type II, \u2018DFG-out\u2019 inhibitors","volume":"40","author":"Modi","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"10","key":"10.1016\/j.fitote.2025.106990_bb0130","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3390\/cells11101694","article-title":"Mediating EGFR-TKI resistance by VEGF\/VEGFR autocrine pathway in non-small cell lung Cancer","volume":"11","author":"Osude","year":"2022","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.fitote.2025.106990_bb0135","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1158\/1541-7786.MCR-12-0652","article-title":"Activation of the FGF2-FGFR1 autocrine pathway: a novel mechanism of acquired resistance to gefitinib in NSCLC","volume":"11","author":"Terai","year":"2013","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.fitote.2025.106990_bb0140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3892\/ijo.2023.5474","article-title":"Dual inhibition of EGFR-VEGF: an effective approach to the treatment of advanced non-small cell lung cancer with EGFR mutation (review)","volume":"62","author":"Wang","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.fitote.2025.106990_bb0145","doi-asserted-by":"crossref","first-page":"106331","DOI":"10.1016\/j.phrs.2022.106331","article-title":"Role of angiopoietin-tie axis in vascular and lymphatic systems and therapeutic interventions","volume":"182","author":"Wang","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"687","key":"10.1016\/j.fitote.2025.106990_bb0150","doi-asserted-by":"crossref","first-page":"149130","DOI":"10.1016\/j.bbrc.2023.149130","article-title":"Therapeutic targeting of angiopoietins in tumor angiogenesis and cancer development","author":"Thapa","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.fitote.2025.106990_bb0155","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/j.1349-7006.2008.00961.x","article-title":"Angiopoietin-1 alters tumor growth by stabilizing blood vessels or by promoting angiogenesis","volume":"99","author":"Satoh","year":"2008","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.fitote.2025.106990_bb0160","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1161\/01.ATV.21.4.536","article-title":"Expression of angiopoietin-1 in human glioblastomas regulates tumor-induced angiogenesis: in vivo and in vitro studies","volume":"21","author":"Audero","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Fitoterapia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X25006161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X25006161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:19:03Z","timestamp":1768479543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0367326X25006161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":32,"alternative-id":["S0367326X25006161"],"URL":"https:\/\/doi.org\/10.1016\/j.fitote.2025.106990","relation":{},"ISSN":["0367-326X"],"issn-type":[{"value":"0367-326X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual inhibition of angiogenesis by Peucedanum praeruptorum Dunn root extract in endothelial and gefitinib-resistant lung cancer cells","name":"articletitle","label":"Article Title"},{"value":"Fitoterapia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fitote.2025.106990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106990"}}